Conventionally-fractionated image-guided intensity modulated radiotherapy (IG-IMRT): a safe and effective treatment for cancer spinal metastasis

Youling Gong, Jin Wang, Sen Bai, Xiaoqin Jiang, Feng Xu, Youling Gong, Jin Wang, Sen Bai, Xiaoqin Jiang, Feng Xu

Abstract

Background: Treatments for cancer spinal metastasis were always palliative. This study was conducted to investigate the safety and effectiveness of IG-IMRT for these patients.

Methods: 10 metastatic lesions were treated with conventionally-fractionated IG-IMRT. Daily kilovoltage cone-beam computed tomography (kV-CBCT) scan was applied to ensure accurate positioning. Plans were evaluated by the dose-volume histogram (DVH) analysis.

Results: Before set-up correction, the positioning errors in the left-right (LR), superior-inferior (SI) and anterior-posterior (AP) axes were 0.3 +/- 3.2, 0.4 +/- 4.5 and -0.2 +/- 3.9 mm, respectively. After repositioning, those errors were 0.1 +/- 0.7, 0 +/- 0.8 and 0 +/- 0.7 mm, respectively. The systematic/random uncertainties ranged 1.4-2.3/3.0-4.1 before and 0.1-0.2/0.7-0.8 mm after online set-up correction. In the original IMRT plans, the average dose of the planning target volume (PTV) was 61.9 Gy, with the spinal cord dose less than 49 Gy. Compared to the simulated PTVs based on the pre-correction CBCT, the average volume reduction of PTVs was 42.3% after online correction. Also, organ at risk (OAR) all benefited from CBCT-based set-up correction and had significant dose reduction with IGRT technique. Clinically, most patients had prompt pain relief within one month of treatment. There was no radiation-induced toxicity detected clinically during a median follow-up of 15.6 months.

Conclusion: IG-IMRT provides a new approach to treat cancer spinal metastasis. The precise positioning ensures the implementation of optimal IMRT plan, satisfying both the dose escalation of tumor targets and the radiation tolerance of spinal cord. It might benefit the cancer patient with spinal metastasis.

Figures

Figure 1
Figure 1
The maximum, minimum and mean dose of the 10 metastatic lesions (PTV) in treatment plans and the average level.
Figure 2
Figure 2
The maximum dose of the spinal cord in treatment plans and the average level.
Figure 3
Figure 3
The homogeneity index/dose conformity index and the average level in treatment plans (1, 2, 3..10 represented the number of the IMRT plans, respectively).
Figure 4
Figure 4
A representative IMRT plan with radiation isodose curves. The PTV (red region) was covered by the 95% curve of the prescription dose (the green line), and the dose of the adjacent cord was less than 49 Gy. (a: transverse section and b: sagittal section).
Figure 5
Figure 5
Comparison of the simulated effects of the positioning errors with/without CBCT-based online set-up correction in the LR, SI and AP axes on the irradiation dose of the spinal cord with the actual plan (red and orange line: isocenter moving left/right in LR axis, yellow and deep green lines: isocenter moving superior/inferior in SI axis, blue and purple lines: isocenter moving anterior/posterior in AP axis, respectively; and the green line was the actual DVH of the cord). (a: the simulated and actual DVHs of the cord and b: the simulated and actual maximum dose of 5% volume of the cord).

References

    1. Schmidt MH, Klimo P, Jr, Vrionis FD. Metastatic spinal cord compression. J Natl Compr Canc Netw. 2005;3:711–719.
    1. Steinmetz MP, Mekhail A, Benzel EC. Management of metastatic tumors of the spine: strategies and operative indications. Neurosurg Focus. 2001;11:e2. doi: 10.3171/foc.2001.11.6.3.
    1. Barton R, Robinson G, Gutierrez E, Kirkbride P, McLean M. Palliative radiation for vertebral metastases: the effect of variation in prescription parameters on the dose received at depth. Int J Radiat Oncol Biol Phys. 2002;52:1083–1091.
    1. Wu JS, Wong R, Johnston M, Bezjak A, Whelan T, Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group Cancer care ontario practice guidelines initiative supportive care group: meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003;55:594–605.
    1. Chi JH, Parsa AT. Intramedullary spinal cord metastasis: clinical management and surgical considerations. Neurosurg Clin N Am. 2006;17:45–50. doi: 10.1016/j.nec.2005.10.003.
    1. Witham TF, Khavkin YA, Gallia GL, Wolinsky JP, Gokaslan ZL. Surgery insight: current management of epidural spinal cord compression from metastatic spine disease. Nat Clin Pract Neurol. 2006;2:87–94. doi: 10.1038/ncpneuro0116.
    1. Bilsky MH. New therapeutics in spine metastases. Expert Rev Neurother. 2005;5:831–840. doi: 10.1586/14737175.5.6.831.
    1. Ryu SI, Chang SD, Kim DH, Murphy MJ, Le QT, Martin DP, Adler JR., Jr Image-guided hypofractionated stereotactic radiosurgery to spinal lesions. Neurosurgery. 2001;49:838–846. doi: 10.1097/00006123-200110000-00011.
    1. Gerszten PC, Burton SA, Belani CP, Ramalingam S, Friedland DM, Ozhasoglu C, Quinn AE, McCue KJ, Welch WC. Radiosurgery for the treatment of spinal lung metastases. Cancer. 2006;107:2653–2661. doi: 10.1002/cncr.22299.
    1. Gerszten PC, Burton SA, Ozhasoglu C. CyberKnife radiosurgery for spinal neoplasms. Prog Neurol Surg. 2007;20:340–358.
    1. Chang EL, Shiu AS, Mendel E, Mathews LA, Mahajan A, Allen PK, Weinberg JS, Brown BW, Wang XS, Woo SY, Cleeland C, Maor MH, Rhines LD. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine. 2007;7:151–160. doi: 10.3171/SPI-07/08/151.
    1. Ryu S, Rock J, Rosenblum M, Kim JH. Patterns of failure after single-dose radiosurgery for spinal metastasis. J Neurosurg. 2004;101:402–405.
    1. Clinical user manual for XVI, Elekta synergy, ELEKTA. 2005. pp. A–7.
    1. van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol. 2004;14:52–64. doi: 10.1053/j.semradonc.2003.10.003.
    1. Yan D, Lockman D, Martinez A, Wong J, Brabbins D, Vicini F, Liang J, Kestin L. Computed tomography guided management of interfractional patient variation. Semin Radiat Oncol. 2005;15:168–179. doi: 10.1016/j.semradonc.2005.01.007.
    1. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) [Editorial] Int J Radiat Oncol Biol Phys. 1995;31:1341–1346.
    1. Marcus RB, Jr, Million RR. The incidence of myelitis after irradiation of the cervical spinal cord. Int J Radiat Oncol Biol Phys. 1990;19:3–8.
    1. Rades D, Stalpers LJ, Veninga T, Schulte R, Hoskin PJ, Obralic N, Bajrovic A, Rudat V, Schwarz R, Hulshof MC, Poortmans P, Schild SE. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol. 2005;23:3366–3375. doi: 10.1200/JCO.2005.04.754.
    1. Fowler JF. The linear quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62:679–694.
    1. Giller CA, Berger BD. New frontiers in radiosurgery for the brain and body. Proc (Bayl Univ Med Cent) 2005;18:311–319.
    1. Yamada Y, Lovelock DM, Yenice KM, Bilsky MH, Hunt MA, Zatcky J, Leibel SA. Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: a preliminary report. Int J Radiat Oncol Biol Phys. 2005;62:53–61. doi: 10.1016/j.ijrobp.2004.09.006.
    1. Yenice KM, Lovelock DM, Hunt MA, Lutz WR, Fournier-Bidoz N, Hua CH, Yamada J, Bilsky M, Lee H, Pfaff K, Spirou SV, Amols HI. CT image-guided intensity-modulated therapy for paraspinal tumors using stereotactic immobilization. Int J Radiat Oncol Biol Phys. 2003;55:583–593.
    1. Mahan SL, Ramsey CR, Scaperoth DD, Chase DJ, Byrne TE. Evaluation of image-guided helical tomotherapy for the retreatment of spinal metastasis. Int J Radiat Oncol Biol Phys. 2005;63:1576–1583. doi: 10.1016/j.ijrobp.2005.05.015.
    1. Chang EL, Shiu AS, Lii MF, Rhines LD, Mendel E, Mahajan A, Weinberg JS, Mathews LA, Brown BW, Maor MH, Cox JD. Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys. 2004;59:1288–1294. doi: 10.1016/j.ijrobp.2004.01.002.
    1. van Herk M, Remeijer P, Lebesque JV. Inclusion of geometric uncertainties in treatment plan evaluation. Int J Radiat Oncol Biol Phys. 2002;52:1407–1422.
    1. Guckenberger M, Meyer J, Wilbert J, Baier K, Bratengeier K, Vordermark D, Flentje M. Precision required for dose-escalated treatment of spinal metastases and implications for image-guided radiation therapy (IGRT) Radiother Oncol. 2007;84:56–63. doi: 10.1016/j.radonc.2007.05.021.
    1. Guckenberger M, Meyer J, Wilbert J, Baier K, Sauer O, Flentje M. Precision of image-guided radiotherapy (IGRT) in six degrees of freedom and limitations in clinical practice. Strahlenther Onkol. 2007;183:307–313. doi: 10.1007/s00066-007-1695-0.
    1. Cai J, Sheng K, Sheehan JP, Benedict SH, Larner JM, Read PW. Evaluation of thoracic spinal cord motion using dynamic MRI. Radiother Oncol. 2007;84:279–282. doi: 10.1016/j.radonc.2007.06.008.
    1. Bortfeld T, Jokivarsi K, Goitein M, Kung J, Jiang SB. Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation. Phys Med Biol. 2002;47:2203–2220. doi: 10.1088/0031-9155/47/13/302.
    1. Chui CS, Yorke E, Hong L. The effects of intra-fraction organ motion on the delivery of intensity-modulated field with a multileaf collimator. Med Phys. 2003;30:1736–1746. doi: 10.1118/1.1578771.
    1. Leunens G, Menten J, Weltens C, Verstraete J, Schueren E van der. Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumors. Radiother Oncol. 1993;29:169–175. doi: 10.1016/0167-8140(93)90243-2.
    1. Fiorino C, Reni M, Bolognesi A, Cattaneo GM, Calandrino R. Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. Radiother Oncol. 1998;47:285–292. doi: 10.1016/S0167-8140(98)00021-8.
    1. Dubois DF, Prestidge BR, Hotchkiss LA, Prete JJ, Bice WS., Jr Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. Radiology. 1998;207:785–789.
    1. Onimaru R, Shirato H, Aoyama H, Kitakura K, Seki T, Hida K, Fujita K, Kagei K, Nishioka T, Kunieda T, Iwasaki Y, Miyasaka K. Calculation of rotational setup error using the real-time tracking radiation therapy (RTRT) system and its application to the treatment of spinal schwannoma. Int J Radiat Oncol Biol Phys. 2002;54:939–947.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever